Search Within

Larry Norton

Formats
  1. Journal Article (409)
  2. Meeting Abstract (295)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (758)
  2. Breast Medicine Service (758)
  3. Department of Medicine (758)
  4. Solid Tumor Oncology Division (758)
  5. Survivorship Research (392)
  6. GSK Faculty (222)

More Groups

People
  1. Clifford Hudis (293)
  2. Edi Brogi (114)
  3. Andrew Seidman (99)
  4. Sujata Patil (97)
  5. Mark Robson (89)
  6. Hannah Wen (82)

More People

Years
  1. 2025 (5)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (30)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (159)
  2. American Association for Cancer Research (124)
  3. Nature Publishing Group (75)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (48)

More Publishers

Results (758)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D. B.; Norton, L.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
    Journal Article

    Mandelker, D.; Kumar, R.; Pei, X.; Selenica, P.; Setton, J.; Arunachalam, S.; Ceyhan-Birsoy, O.; Brown, D. N.; Norton, L.; Robson, M. E.; more...
    JNCI Cancer Spectrum (2019)

    Fulltext@MSK | Save
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Multisystem toxicity in cancer: Lessons from NASA's countermeasures program
    Editorial

    Scott, J. M.; Dolan, L. B.; Norton, L.; Charles, J. B.; Jones, L. W.
    Cell (2019)

    Fulltext@MSK | Save
  • Molecular profiling of ER plus metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors
    Meeting Abstract

    Razavi, P.; dos Anjos, C. H.; Brown, D. N.; Qing, L.; Ping, C.; Herbert, J.; Colon, J.; Liu, D.; Mao, M.; Norton, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A large retrospective analysis of CDK 4/6 inhibitor retreatment in ER+ metastatic breast cancer (MBC)
    Meeting Abstract

    dos Anjos, C. H.; Razavi, P.; Herbert, J.; Colon, J.; Gill, K.; Modi, S.; Bromberg, J.; Dang, C. T.; Liu, D.; Norton, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC)
    Meeting Abstract

    Comen, E. A.; Bryce, Y.; Page, D. B.; Solomon, S. B.; Rodine, M.; Abaya, C. D.; Morris, E. A.; Plitas, G.; El-Tamer, M.; Gemignani, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Gluthathione peroxidase 2 downregulation in the PyMT mammary tumor model leads to an aggressive phenotype due to stimulation of angiogenesis and tumor stemness via HIF1 alpha signaling
    Meeting Abstract

    Ren, Z.; Liang, H.; Benard, O.; Suyama, K.; Albanese, J. M.; Norton, L.; Zheng, W.; Hazan, R. B.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A small-molecule pan-Id antagonist inhibits pathologic ocular neovascularization
    Journal Article

    Wojnarowicz, P. M.; Lima e Silva, R.; Ohnaka, M.; Lee, S. B.; Chin, Y.; Kulukian, A.; Chang, S. H.; Desai, B.; Garcia Escolano, M.; Shah, R.; more...
    Cell Reports (2019)

    Fulltext@MSK | Save
  • Clinicopathologic features of breast cancers with HER2/CEP17 ratio < 2, HER2 copy number ≥ 4 and < 6 signals/cell
    Meeting Abstract

    Xu, J.; Brogi, E.; Ventura, K.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H.
    Modern Pathology (2019)

    Fulltext@MSK | Save